In this region, The APAC injectable drug delivery market is projected to reach USD 143,089.37 million by 2024, from USD 56,198.43 million in 2016 growing at a CAGR of 12.4% in the forecast period 2017 to 2024.
Based on geography, the APAC injectable drug delivery market is segmented into 11 geographical regions, such as,
Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest Of APAC.
APAC injectable drug delivery market competition by top players including –
Some of the major players operating in this market are
Baxter International, Inc.,
Becton Dickinson and Company,
Gerresheimer AG, Pfizer, Inc.,
Schott AG, Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Ypsomed,
Bespak.
The APAC injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.
The APAC injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anaemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, direct tender, and online pharmacy.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. OVERVIEW OF ASIA PACIFIC INJECTABLEDRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. NEEDLESTICK INJURIES AND INFECTIONS
3.2.2. HIGH COST OF DEVELOPMENT
3.2.3. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)
7. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY TYPE
7.1. OVERVIEW
7.2. INJECTABLE DRUG DELIVERY DEVICES
7.2.1. CONVENTIONAL INJECTION DEVICES
7.2.2. SELF INJECTION DEVICES
7.2.2.1. NEEDLE FREE INJECTORS (NFI)
7.2.2.2. AUTO INJECTORS
7.2.2.3. PEN INJECTORS
7.2.2.4. WEARABLE INJECTORS
7.3. INJECTABLE DRUG DELIVERY FORMULATION
7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
7.3.1.1. SOLUTIONS
7.3.1.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS
7.3.1.3. SUSPENSIONS
7.3.1.4. EMULSIONS
7.3.2. NOVEL DRUG DELIVERY FORMULATIONS
7.3.2.1. COLLOIDAL DISPERSIONS
7.3.2.2. MICROPARTICLES
7.3.2.3. LONG ACTING INJECTION FORMULATION
8. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS
8.3.1. INJECTABLE DRUGS FOR DIABETES
8.3.2. INJECTABLE DRUGS FOR ANEMIA
8.3.3. INJECTABLE DRUGS FOR REPRODUCTIVE HEALTH DISEASE
8.3.4. INJECTABLE DRUGS FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY
8.3.5. INJECTABLE DRUGS FOR OSTEOPOROSIS
8.3.6. INJECTABLE DRUGS FOR GROWTH HORMONE DISORDERS (GHD)
8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES
8.5.1. INJECTABLE DRUGS FOR RHEUMATOID ARTHRITIS
8.5.2. INJECTABLE DRUGS FOR MULTIPLE SCLEROSIS
8.5.3. INJECTABLE DRUGS FOR CROHN’S DISEASES
8.5.4. INJECTABLE DRUGS FOR PSORIASIS
8.5.5. INJECTABLE DRUGS FOR OTHER AUTOIMMUNE DISEASES
8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS
8.7.1. INJECTABLE DRUGS FOR PAIN MANAGEMENT
8.7.2. INJECTABLE DRUGS FOR ALLERGY TREATMENT
8.7.3. INJECTABLE DRUGS FOR AESTHETIC TREATMENTS
8.7.4. INJECTABLE DRUGS FOR HEPATITIS C
8.7.5. INJECTABLE DRUGS FOR HEMOPHILIA
9. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN
10. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM
11. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS
12. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.1.1. HOSPITAL PHARMACY
12.1.2. PHARMACY STORES
12.1.3. DIRECT TENDER
12.1.4. ONLINE PHARMACY
13. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
13.1. OVERVIEW
13.2. APAC INJECTABLE DRUG DELIVERY MARKET
13.2.1. JAPAN INJECTABLE DRUG DELIVERY MARKET
13.2.2. CHINA INJECTABLE DRUG DELIVERY MARKET
13.2.3. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET
13.2.4. INDIA INJECTABLE DRUG DELIVERY MARKET
13.2.5. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET
13.2.6. SINGAPORE INJECTABLE DRUG DELIVERY MARKET
13.2.7. THAILAND INJECTABLE DRUG DELIVERY MARKET
13.2.8. MALAYSIA INJECTABLE DRUG DELIVERY MARKET
13.2.9. INDONESIA INJECTABLE DRUG DELIVERY MARKET
13.2.10. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET
13.2.11. REST OF APAC INJECTABLE DRUG DELIVERY MARKET
14. ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
14.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC
15. COMPANY PROFILES
15.1. BECTON, DICKINSON AND COMPANY
15.1.1. COMPANY OVERVIEW
15.1.1.1. DRIVERS EXPLAINED
15.1.1.2. WEAKNESSES EXPLAINED
15.1.1.3. OPPURTUNITIES EXPLAINED
15.1.1.4. THREATS EXPLAINED
15.1.2. PRODUCT PORTFOLIO
15.1.3. RECENT DEVELOPMENTS
15.2. PFIZER
15.2.1. COMPANY OVERVIEW
15.2.1.1. DRIVERS EXPLAINED
15.2.1.2. WEAKNESSES EXPLAINED
15.2.1.3. OPPURTUNITIES EXPLAINED
15.2.1.4. THREATS EXPLAINED
15.2.2. PRODUCT PORTFOLIO
15.2.3. RECENT DEVELOPMENTS
15.3. BAXTER INTERNATIONAL
15.3.1. COMPANY OVERVIEW
15.3.1.1. DRIVERS EXPLAINED
15.3.1.2. WEAKNESSES EXPLAINED
15.3.1.3. OPPURTUNITIES EXPLAINED
15.3.1.4. THREATS EXPLAINED
15.3.2. PRODUCT PORTFOLIO
15.3.3. RECENT DEVELOPMENTS
15.4. GERRESHEIMER AG
15.4.1. COMPANY OVERVIEW
15.4.2. PRODUCT PORTFOLIO
15.4.3. RECENT DEVELOPMENTS
15.5. SCHOTT AG INC.
15.5.1. COMPANY OVERVIEW
15.5.2. PRODUCT PORTFOLIO
15.5.3. RECENT DEVELOPMENTS
15.6. ALKERMES INC.
15.6.1. COMPANY OVERVIEW
15.6.2. PRODUCT PORTFOLIO
15.6.3. RECENT DEVELOPMENTS
15.7. ANTARES PHARMA
15.7.1. COMPANY OVERVIEW
15.7.2. PRODUCT PORTFOLIO
15.7.3. RECENT DEVELOPMENTS
15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
15.8.1. COMPANY OVERVIEW
15.8.2. PRODUCT PORTFOLIO
15.8.3. RECENT DEVELOPMENTS
15.9. ELCAM MEDICAL
15.9.1. COMPANY OVERVIEW
15.9.2. PRODUCT PORTFOLIO
15.9.3. RECENT DEVELOPMENTS
15.10. ELI LILLY AND COMPANY
15.10.1. COMPANY OVERVIEW
15.10.1.1. DRIVERS EXPLAINED
15.10.1.2. WEAKNESSES EXPLAINED
15.10.1.3. OPPURTUNITIES EXPLAINED
15.10.1.4. THREATS EXPLAINED
15.10.2. PRODUCT PORTFOLIO
15.10.3. RECENT DEVELOPMENTS
15.11. HASELMEIER
15.11.1. COMPANY OVERVIEW
15.11.2. PRODUCT PORTFOLIO
15.11.3. RECENT DEVELOPMENTS
15.12. MYLAN N.V.
15.12.1. COMPANY OVERVIEW
15.12.2. PRODUCT PORTFOLIO
15.12.3. RECENT DEVELOPMENTS
15.13. NOVO NORDISK
15.13.1. COMPANY OVERVIEW
15.13.2. PRODUCT PORTFOLIO
15.13.3. RECENT DEVELOPMENTS
15.14. OWEN MUMFORD LTD
15.14.1. COMPANY OVERVIEW
15.14.2. PRODUCT PORTFOLIO
15.14.3. RECENT DEVELOPMENTS
15.15. SANDOZ INTERNATIONAL GMBH
15.15.1. COMPANY OVERVIEW
15.15.2. PRODUCT PORTFOLIO
15.15.3. RECENT DEVELOPMENTS
15.16. SANOFI
15.16.1. COMPANY OVERVIEW
15.16.2. PRODUCT PORTFOLIO
15.16.3. RECENT DEVELOPMENTS
15.17. TERUMO CORPORATION
15.17.1. COMPANY OVERVIEW
15.17.2. PRODUCT PORTFOLIO
15.17.3. RECENT DEVELOPMENTS
15.18. TEVA PHARMACEUTICAL
15.18.1. COMPANY OVERVIEW
15.18.1.1. DRIVERS EXPLAINED
15.18.1.2. WEAKNESSES EXPLAINED
15.18.1.3. OPPURTUNITIES EXPLAINED
15.18.1.4. THREATS EXPLAINED
15.18.2. PRODUCT PORTFOLIO
15.18.3. RECENT DEVELOPMENTS
15.19. WEST PHARMACEUTICAL SERVICES, INC
15.19.1. COMPANY OVERVIEW
15.19.2. PRODUCT PORTFOLIO
15.19.3. RECENT DEVELOPMENTS
15.20. YPSOMED HOLDING AG
15.20.1. COMPANY OVERVIEW
15.20.2. PRODUCT PORTFOLIO
15.20.3. RECENT DEVELOPMENTS
16. RELATED REPORTS
TABLE LIST
TABLE 1 APAC INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 APAC INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 3 APAC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 4 APAC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 5 APAC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 6 APAC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 7 APAC SELF INJECTION DEVICE MARKET, BY TYPE,2015 – 2024(USD MILLION)
TABLE 8 APAC NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 9 APAC NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 10 APAC NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 11 APAC AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 12 APAC AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 13 APAC AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 14 APAC AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 15 APAC PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 16 APAC PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 17 APAC PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 18 APAC INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 19 APAC CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 20 APAC NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 21 APAC COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 22 APAC NANOPARTICLES COLLOIDAL DISPERSIONS NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 23 APAC MICROPARTICLES NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 24 APAC INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 25 APAC AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 26 APAC HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 27 APAC OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 28 APAC INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 29 APAC INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 30 APAC INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 31 APAC INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 32 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 33 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 34 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 35 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 36 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 37 JAPAN SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 38 JAPAN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 39 JAPAN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 40 JAPAN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 41 JAPAN AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 42 JAPAN AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 43 JAPAN AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 44 JAPAN AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 45 JAPAN PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 46 JAPAN PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 47 JAPAN PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 48 JAPAN INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 49 JAPAN CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 50 JAPAN NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 51 JAPAN COLLOIDAL DISPERSION NOVEL DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 52 JAPAN NANOPARTICLES COLLOIDAL DISPERSIONS NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 53 JAPAN MICROPARTICLES NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 54 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 JAPAN AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 56 JAPAN HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 57 JAPAN OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 58 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 59 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 60 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 61 JAPAN INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 62 CHINA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 63 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 64 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 65 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 66 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 67 CHINA SELF INJECTION DEVICE MARKET, BY TYPE,2015 – 2024(USD MILLION)
TABLE 68 CHINA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 69 CHINA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 70 CHINA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 71 CHINA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 72 CHINA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 73 CHINA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 74 CHINA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 75 CHINA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 76 CHINA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 77 CHINA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 78 CHINA INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 79 CHINA CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 80 CHINA NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 81 CHINA COLLOIDAL DISPERSION NOVEL DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 82 CHINA NANOPARTICLES COLLOIDAL DISPERSIONS NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 83 CHINA MICROPARTICLES NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 84 CHINA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 85 CHINA AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 86 CHINA HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 87 CHINA OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 88 CHINA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 89 CHINA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 90 CHINA INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 91 CHINA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 92 SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 93 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 94 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 95 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 96 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 97 SOUTH KOREA SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 98 SOUTH KOREA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 99 SOUTH KOREA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 100 SOUTH KOREA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 101 SOUTH KOREA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 102 SOUTH KOREA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 103 SOUTH KOREA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 104 SOUTH KOREA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 105 SOUTH KOREA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 –2024(USD MILLION)
FIGURES LIST
FIGURE 1 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
FIGURE 5 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: BOTTOM UP APPROACH
FIGURE 6 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: TOP DOWN APPROACH
FIGURE 7 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 22 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SNAPSHOT (2017)
+1 888 709 8757
Chat With Us